Prostate Cancer

EA8183 / ERADICATE


A Phase III Double Blinded Study of Early Intervention after Radical Prostatectomy with Androgen Deprivation Therapy with or without Darolutamide vs. Placebo in Men at Highest Risk of Prostate Cancer Metastasis by Genomic Stratification (ERADICATE)

Physician and Research Staff Educational Material

This material is intended for promotional use among health care professionals and is NOT intended for use as patient educational material.

ECOG-ACRIN Cancer Research Group